Research Archives - American Brain Tumor Association

Brain Tumor Funders’ Collaborative Announces New Grant Opportunity to Support Studies on Liquid Biopsy in Primary Brain Tumors

Brain Tumor Funders’ Collaborative Announces New Grant Opportunity to Support Studies on Liquid Biopsy in Primary Brain Tumors The Brain Tumor Funders’ Collaborative (BTFC) announced a request for proposals for

The American Brain Tumor Association Funds 24 New Projects to Push Brain Cancer Research Forward

Meet the 2024 ABTA grant recipients at the forefront of the brain tumor research community. Donations from individuals to large groups in the brain tumor community have been the engine

Understanding Immunotherapy and Brain Tumors: A Path Forward

The American Brain Tumor Association recently hosted a webinar focused on Immunotherapy and Brain Tumors, featuring insights from Dr. Peter Fecci, Director of the Brain Tumor Immunotherapy Program at Duke

Exploring New Frontiers: Y-90 Internal Radiation Trial for Recurrent Glioblastoma

**Sponsored Content**

Learn about an active clinical trial studying Y-90, an internal radiation treatment that aims to directly target brain cancer while minimizing harm to surrounding healthy tissue.

Uncovering New Approaches to Accelerate GBM Treatment

In recognition of GBM Awareness Day, discover two emerging researchers taking novel approaches to overcome obstacles in treating glioblastoma.

Collaboration & Hope: Highlights from the SNO/ASCO Central Nervous System Metastases Conference

The Society for Neuro-Oncology (SNO)/American Society of Clinical Oncology (ASCO) Central Nervous System (CNS) Metastases Conference brought together leading experts, researchers, and clinicians from around the world to discuss the

FDA Approves Vorasidenib, a New Treatment for Low-Grade Gliomas

A new treatment called vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for people with low-grade gliomas (LGG). This type of brain tumor grows slowly but

When Melanoma Metastasizes to the Brain

Explore the risks of melanoma metastasizing to the brain and join an upcoming webinar to empower yourself or a loved one.

New Statistical Report Reveals Primary Brain and Central Nervous System Tumors as Second Most Common Cancer Type in Adolescents and Young Adults

CHICAGO (May 7, 2024)—Today, the American Brain Tumor Association (ABTA), in partnership with the National Institutes of Health’s National Cancer Institute (NCI) Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) program and the Central Brain Tumor Registry of the United States (CBTRUS), unveiled a new report shedding light on the prevalence of primary brain and other central nervous system (CNS) tumors among adolescents and young adults (AYAs) between the ages of 15 and 39.